Wed, January 11, 2023
Tue, January 10, 2023
Mon, January 9, 2023
Sun, January 8, 2023
Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023

Jonathan Wolleben Maintained (SPRB) at Buy and Held Target at $8 on, Jan 8th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. at-buy-and-held-target-at-8-on-jan-8th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jonathan Wolleben of JMP Securities, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $8 on, Jan 8th, 2023.

Jonathan has made no other calls on SPRB in the last 4 months.



There is 1 other peer that has a rating on SPRB. Out of the 1 peers that are also analyzing SPRB, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $8 on, Thursday, November 17th, 2022

Publication Contributing Sources